Saturday, July 11, 2026

pharma · Sepsis · Tumor, Solid

Sichuan Kelun Pharmaceutical

Sichuan Kelun Pharmaceutical drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

CN HQ
375 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
375
Programs
4
Drugs
6
Patents
0
Intelligence · Drug Pipeline

Sichuan Kelun Pharmaceutical pipeline

Portfolio lens on 6 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Sichuan Kelun Pharmaceutical drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

6 compounds
  1. Development asset linked to Sichuan Kelun Pharmaceutical in public FDA and regional records.

  2. Development asset linked to Sichuan Kelun Pharmaceutical in public FDA and regional records.

  3. Development asset linked to Sichuan Kelun Pharmaceutical in public FDA and regional records.

  4. Development asset linked to Sichuan Kelun Pharmaceutical in public FDA and regional records.

  5. Development asset linked to Sichuan Kelun Pharmaceutical in public FDA and regional records.

  6. Development asset linked to Sichuan Kelun Pharmaceutical in public FDA and regional records.